Co-Diagnostics, Inc. (CODX): Price and Financial Metrics

Co-Diagnostics, Inc. (CODX): $1.09

0.05 (-4.39%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

CODX Price/Volume Stats

Current price $1.09 52-week high $1.89
Prev. close $1.14 52-week low $0.98
Day low $1.09 Volume 58,800
Day high $1.17 Avg. volume 62,827
50-day MA $1.16 Dividend yield N/A
200-day MA $1.19 Market Cap 34.09M

CODX Stock Price Chart Interactive Chart >


Co-Diagnostics, Inc. (CODX) Company Bio


Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.


CODX Latest News Stream


Event/Time News Detail
Loading, please wait...

CODX Latest Social Stream


Loading social stream, please wait...

View Full CODX Social Stream

Latest CODX News From Around the Web

Below are the latest news stories about CO-DIAGNOSTICS INC that investors may wish to consider to help them evaluate CODX as an investment opportunity.

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has submitted its Co-Dx™ PCR COVID-19 test with Co-Dx PCR Pro™ instrument for review by the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA). The submission includes the PCR Pro instrument, COVID-19 detection test, and mobile app, all designed for use in point-of-

Yahoo | December 27, 2023

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting at the Piper Sandler 35th Annual Healthcare Conference in New York City, New York on November 30, 2023.

Yahoo | November 29, 2023

Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript November 9, 2023 Co-Diagnostics, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.29. Operator: Hello. Welcome to the Co-Diagnostics Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note today’s event is being recorded. I would now like […]

Yahoo | November 10, 2023

Q3 2023 Co-Diagnostics Inc Earnings Call

Q3 2023 Co-Diagnostics Inc Earnings Call

Yahoo | November 10, 2023

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2023.

Yahoo | November 9, 2023

Read More 'CODX' Stories Here

CODX Price Returns

1-mo -6.03%
3-mo -6.03%
6-mo -24.31%
1-year -21.01%
3-year -87.27%
5-year 25.43%
YTD -18.05%
2023 -47.22%
2022 -71.78%
2021 -3.98%
2020 938.87%
2019 -39.92%

Continue Researching CODX

Want to see what other sources are saying about Co-Diagnostics Inc's financials and stock price? Try the links below:

Co-Diagnostics Inc (CODX) Stock Price | Nasdaq
Co-Diagnostics Inc (CODX) Stock Quote, History and News - Yahoo Finance
Co-Diagnostics Inc (CODX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!